What is the official website of Travere Therapeutics ?

The official website of Travere Therapeutics is https://www.travere.com.

What is Travere Therapeutics's cybersecurity risk score?

Travere Therapeutics has an AI-generated cybersecurity risk score of 714 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has Travere Therapeutics experienced?

According to Rankiteo, Travere Therapeutics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Travere Therapeutics been affected by any supply chain cyber incidents ?

According to Rankiteo, Travere Therapeutics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Travere Therapeutics have SOC 2 Type 1 certification ?

According to Rankiteo, Travere Therapeutics is not certified under SOC 2 Type 1.

Does Travere Therapeutics have SOC 2 Type 2 certification ?

According to Rankiteo, Travere Therapeutics does not hold a SOC 2 Type 2 certification.

Does Travere Therapeutics comply with GDPR ?

According to Rankiteo, Travere Therapeutics is not listed as GDPR compliant.

Does Travere Therapeutics have PCI DSS certification ?

According to Rankiteo, Travere Therapeutics does not currently maintain PCI DSS compliance.

Does Travere Therapeutics comply with HIPAA ?

According to Rankiteo, Travere Therapeutics is not compliant with HIPAA regulations.

Does Travere Therapeutics have ISO 27001 certification ?

According to Rankiteo,Travere Therapeutics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Travere Therapeutics operate in ?

Travere Therapeutics operates primarily in the Biotechnology industry.

How many employees does Travere Therapeutics have ?

Travere Therapeutics employs approximately 466 people worldwide.

Does Travere Therapeutics own any subsidiaries ?

Travere Therapeutics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Travere Therapeutics have ?

Travere Therapeutics's official LinkedIn profile has approximately 37,169 followers.

Does Travere Therapeutics have a Crunchbase profile ?

No, Travere Therapeutics does not have a profile on Crunchbase.

Does Travere Therapeutics have a LinkedIn profile ?

Yes, Travere Therapeutics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/travererare.

How many cybersecurity incidents has Travere Therapeutics experienced ?

As of October 22, 2026, Rankiteo reports that Travere Therapeutics has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Travere Therapeutics have ?

Travere Therapeutics has an estimated 1,079 peer or competitor companies worldwide.

What types of cybersecurity incidents has Travere Therapeutics faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Travere Therapeutics

Boost Score +25 with badge (5 left)

714

/1000

Moderate

739

/1000

Moderate

Travere Therapeutics Vendor Cyber Rating & Cyber Score

travere.com

Add Your Compliance Badge

Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife Community Guidelines: https://travere.com/community-guidelines/

Travere Therapeutics

Travere Therapeutics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Travere Therapeutic...

Breach

10/2025

TRA539425310272...

Loading…

A.I.

Travere Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Travere Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Travere Therapeutics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Travere Therapeutics in 2026.

Incident Types Travere Therapeutics vs Biotechnology Industry Avg (This Year)

No incidents recorded for Travere Therapeutics in 2026.

Incident History - Travere Therapeutics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Travere Therapeutics Subsidiaries

Travere Therapeutics

Biotechnology

Website: https://www.travere.com

Company Size: 466

RKD & MeBiotechnology Research

Loading…

Travere Therapeutics Similar Companies

Regeneron

regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

Travere Therapeutics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 24, 2026 03:18 PM

Travere Therapeutics, Inc. (TVTX): A Bull Case Theory

We came across a bullish thesis on Travere Therapeutics, Inc. on HalfBakedInnovations's Substack by Biotech Distilled.

Read Article

February 01, 2026 08:00 AM

Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative?

Robbins Geller Rudman & Dowd LLP recently announced it is investigating potential violations of U.S. federal securities laws by Travere...

Read Article

January 29, 2026 08:00 AM

Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think

Travere Therapeutics is focused on rare kidney diseases, with FILSPARI driving significant revenue growth in IgA Nephropathy.

Read Article

January 12, 2026 08:00 AM

Travere Therapeutics Provides Corporate Update and 2026 Outlook

SAN DIEGO, January 12, 2026--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial...

Read Article

December 25, 2025 08:00 AM

Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge?

If you are wondering whether Travere Therapeutics is still good value after its big rebound, you are not alone. This stock has quickly moved...

Read Article

November 06, 2025 08:00 AM

Analysts Just Published A Bright New Outlook For Travere Therapeutics, Inc.'s (NASDAQ:TVTX)

Celebrations may be in order for Travere Therapeutics, Inc. ( NASDAQ:TVTX ) shareholders, with the analysts delivering...

Read Article

November 05, 2025 08:00 AM

Travere Therapeutics Data Breach Investigation

If you were affected by the Travere Therapeutics, Inc data breach, you may be entitled to compensation.

Read Article

November 03, 2025 08:00 AM

Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook

It's been a pretty great week for Travere Therapeutics, Inc. ( NASDAQ:TVTX ) shareholders, with its shares surging 18...

Read Article

November 02, 2025 07:00 AM

Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings

We recently published 10 Stocks With Easy 20-40% Gains. Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the last week's best-performing...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-113705

SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-9825

SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 3.7)

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.2

REFERENCES

https://www.ibm.com/support/pages/node/7290671

CVE-2026-94402

SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Impact Score

2.7

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7291785

CVE-2026-93888

SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.ibm.com/support/pages/node/7292127

CVE-2026-93744

SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

3.9

REFERENCES

https://www.ibm.com/support/pages/node/7292223

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Travere Therapeutics Vendor Cyber Rating & Cyber Score

Travere Therapeutics A.I CyberSecurity Scoring

Travere Therapeutics CyberSecurity News & History

Travere Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Travere Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Travere Therapeutics vs Biotechnology Industry Avg (This Year)

Incident History - Travere Therapeutics (X = Date, Y = Severity)

Travere Therapeutics Subsidiaries

Travere Therapeutics

Travere Therapeutics Similar Companies

Regeneron

Travere Therapeutics CyberSecurity News

Travere Therapeutics, Inc. (TVTX): A Bull Case Theory

Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative?

Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think

Travere Therapeutics Provides Corporate Update and 2026 Outlook

Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge?

Analysts Just Published A Bright New Outlook For Travere Therapeutics, Inc.'s (NASDAQ:TVTX)

Travere Therapeutics Data Breach Investigation

Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook

Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Travere Therapeutics CyberSecurity News & History

Travere Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Travere Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Travere Therapeutics vs Biotechnology Industry Avg (This Year)

Incident History - Travere Therapeutics (X = Date, Y = Severity)

Travere Therapeutics Subsidiaries

Travere Therapeutics

Travere Therapeutics Similar Companies

Regeneron

Travere Therapeutics CyberSecurity News

Travere Therapeutics, Inc. (TVTX): A Bull Case Theory

Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative?

Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think

Travere Therapeutics Provides Corporate Update and 2026 Outlook

Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge?

Analysts Just Published A Bright New Outlook For Travere Therapeutics, Inc.'s (NASDAQ:TVTX)

Travere Therapeutics Data Breach Investigation

Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook

Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo